Venetoclax-Based Regimens for Relapsed/Refractory Acute Myeloid Leukemia in a Real-Life Setting: A Retrospective Single-Center Experience

Relapsed/refractory (R/R) acute myeloid leukemia (AML) is a largely unmet medical need, owing to the lack of standardized, effective treatment approaches, resulting in an overall dismal outcome. The only curative option for R/R AML patients is allogeneic hematopoietic stem cell transplantation (HSCT...

Descripción completa

Detalles Bibliográficos
Autores principales: Piccini, Matteo, Pilerci, Sofia, Merlini, Marta, Grieco, Pietro, Scappini, Barbara, Bencini, Sara, Peruzzi, Benedetta, Caporale, Roberto, Signori, Leonardo, Pancani, Fabiana, Vannucchi, Alessandro Maria, Gianfaldoni, Giacomo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070927/
https://www.ncbi.nlm.nih.gov/pubmed/33919958
http://dx.doi.org/10.3390/jcm10081684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070927/
https://www.ncbi.nlm.nih.gov/pubmed/33919958
http://dx.doi.org/10.3390/jcm10081684

Ejemplares similares